Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update
SOUTH EASTON, Mass., May 15, 2012 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its First Quarter 2012 financial results and to provide a business update. Anyone interested may listen to the teleconference either by telephone or through a live web-cast. The teleconference and web-cast information is provided below:
Date: Wednesday, May 16, 2012
Time: 4:15 p.m. Eastern Daylight Time (EDT)
To attend this teleconference via web-cast, please visit the Company's website:
www.pressurebiosciences.com
To attend this teleconference via telephone:
Dial-in: (888) 383-9147
For those unable to participate in the live teleconference, a replay will be available approximately one hour after the call ends through June 16, 2012, and will be accessible through the Company's website.
About Pressure BioSciences, Inc.
Pressure BioSciences, Inc. ("PBI") (OTCQB: PBIO) is focused on the development, marketing, and sale of proprietary laboratory instrumentation and associated consumables based on Pressure Cycling Technology ("PCT"). PCT is a patented, enabling technology platform with multiple applications in the estimated $6 billion life sciences sample preparation market. PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels to control bio-molecular interactions. PBI currently focuses its efforts on the development and sale of PCT-enhanced sample preparation systems (instruments and consumables) for mass spectrometry, biomarker discovery, bio-therapeutics characterization, vaccine development, soil and plant biology, forensics, histology, and counter-bioterror applications.
Investor Contacts:
Pressure BioSciences, Inc.
Richard T. Schumacher, President & CEO
Joseph Damasio, Jr., VP of Finance & Administration
(T) 508-230-1828
SOURCE Pressure BioSciences, Inc.